But it’s not just staffing changes: 23andMe is also shutting down its entire therapeutics division, which had been working ...
The DNA-testing firm said in a Tuesday SEC filing, “there is substantial doubt about the company’s ability to continue.” ...
Though 23andMe says the restructuring plan will cost it around $12 million, it expects to save more than $35 million as a ...
The genetic testing company 23andMe hasn't been doing so hot lately, watching its share price plummet more than 70% this year ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
Anne Wojcicki; Chairman of the Board, President, Chief Executive Officer, Co-Founder; 23andMe Holding Co. Joseph Selsavage; Interim Chief Financial Officer, Chief Accounting Officer; 23andMe ...